ArticleJACC. Case reports2026
Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile rare, primary cardiac tumors, especially angiosarcomas, have a high mortality rate and are difficult to diagnose due to vague symptoms and limited visibility on transthoracic echocardiogram. CASE SUMMARY: A 47-year-old patient was treated for acute pericarditis with transient resolution of a pericardial effusion but persistent dyspnea, chest pain, fatigue, and elevated inflammatory markers. Six months after the initial presentation, they developed tamponade, had hemorrhagic shock, and passed away due to right atrial rupture from an infiltrative tumor. Pathology demonstrated primary cardiac angiosarcoma. DISCUSSION: This case illustrates the diagnostic challenges and consequences of a cardiac tumor which was not apparent on serial echocardiograms. TAKE-HOME MESSAGES: Primary cardiac malignancy should be considered in the setting of recurrent pericardial effusion with systemic symptoms and persistently elevated inflammatory markers. Echocardiogram has shown low sensitivity for cardiac tumors in the setting of effusion; advanced imaging modalities can facilitate early detection and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.